课题基金 / 基金详情

PEMPHIGUS AS A MODEL ORGAN-SPECIFIC AUTOIMMUNE DISEASE

PEMPHIGUS AS A MODEL ORGAN-SPECIFIC AUTOIMMUNE DISEASE
天疱疮作为器官特异性自身免疫性疾病的模型
批准号:
6323916
负责人:
JEAN-CLAUDE BYSTRYN
金额:
$4.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-03 至 2001-05-05

项目摘要

项目成果

JEAN-CLAUDE BYSTRYN的其他基金

相关文献

中文摘要
翻译
描述(摘自申请者的摘要):天疱疮的目的 会议将把从事基础免疫学研究的科学家聚集在一起 人类自身免疫和天疱疮研究的方面。 主要专家将就自身免疫的基础研究发表演讲 与天疱疮研究报告交替进行。在最后一节中,我们 将探讨人类自身免疫新疗法的主题 疾病和天疱疮。科学家之间思想的交叉杂交,报告 人类自身免疫领域的新发展和新疗法将是 这次会议的目的是。因为天疱疮是一个真正的病理性 器官特异性自身免疫性疾病,天疱疮大会将吸引 致力于研究和治疗这种疾病的科学家和临床医生。
英文摘要
DESCRIPTION (Taken from the applicant's abstract): The purpose of the Pemphigus Conference will be to bring together scientists working in basic immunological aspects of human autoimmunity and those working in pemphigus research. Presentations on basic research on autoimmunity by leading experts will alternate with presentations on pemphigus research. In the last segment, we will approach the subject of new emerging therapies in human autoimmune diseases and pemphigus. Cross-hybridization of ideas among scientists, report of new developments in the area of human autoimmunity and new therapies will be the aim of this conference. Since pemphigus is a true example of pathological organ-specific autoimmune disease, the Pemphigus Conference will attract scientists and clinicians dedicated to investigate and treat this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
SERUM CYT-MAA AS AN EARLY MARKER OF RESPONSE TO THERAPY IN RESECTED MELANOMA
PHASE II RANDOMIZED TRIAL OF IVIG WITH OR WITHOUT CYCLOPHOSPHAMIDE IN PEMPHIGUS
PEMPHIGUS 2005-PROGRESS AND FUTURE DIRECTIONS